Chinese medicine decoction reduce adverse events associated with gouty arthritis
A recent publication in the journal of Medicine proposes that the use of traditional Chinese medicine decoction (TCMD) may serve as a viable complementary and alternative approach to manage gouty arthritis (GA).
This randomized controlled trials focused on TCMD for gouty arthritis were retrieved from both Chinese and English databases. 84 studies including 7151 patients and evaluation of 10 outcome indicators were incorporated in this analysis. Information on the ingredients and targets associated with TCMD and GA was gathered from various databases including TCMSP and DrugBank.
The key findings of this study were:
1.The meta-analysis revealed that TCMD demonstrated superior efficacy in reducing the incidence of adverse events and levels of various laboratory indicators, such as blood uric acid (BUA), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), interleukin 6 (IL-6), interleukin 8 (IL-8), interleukin 1β (IL-1β), and tumor necrosis factor-α (TNF-α) when compared to standard treatment.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.